Latest Articles

Publication Date
Subtype-specific analysis of factors associated with assisted reproductive technology indication and live birth in patients with adenomyosis: a retrospective study.

The magnetic resonance imaging (MRI)-based classification of adenomyosis subtypes helps predict reproductive and obstetric outcomes; however, background factors associated with use of assisted reproductive technology (ART) and live birth within …

Published: June 26, 2026, midnight
Correction: Endometrioid cancer associated with endometriosis: from the seed and soil theory to clinical practice.

[This corrects the article DOI: 10.3389/fonc.2022.859510.].

Published: June 25, 2026, midnight
FAPI PET/MRI detects more endometriosis lesions than MRI alone - AuntMinnieEurope

FAPI PET/MRI detects more endometriosis lesions than MRI alone AuntMinnieEurope

Published: June 22, 2026, 9:16 p.m.
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer - OncLive

Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer OncLive

Published: June 20, 2026, 1:04 p.m.
Path beyond the blind end-unravel the imaging spectrum of appendiceal pathologies.

The appendix is involved in a diverse spectrum of inflammatory, infectious, benign, and malignant conditions that extend far beyond acute appendicitis. Although acute appendicitis remains the most common appendiceal emergency, …

Published: June 20, 2026, midnight
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer - OncLive

Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer OncLive

Published: June 19, 2026, 5:49 p.m.
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology

Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology

Published: June 19, 2026, 5:05 p.m.
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? - ESMO Daily Reporter

Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? ESMO Daily Reporter

Published: June 18, 2026, 2:24 p.m.
Women's Musculoskeletal Health: Insights from the 2024 National Academies of Sciences, Engineering, and Medicine Report on Chronic Conditions.

In 2024, the National Academies of Sciences, Engineering, and Medicine (NASEM) published a report entitled Advancing Research on Chronic Conditions in Women. A major purpose of this report was to …

Published: June 18, 2026, midnight
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer - Medscape Reference

PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer Medscape Reference

Published: June 17, 2026, 2:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!